Get started

More results...

Filter by Content types
Filter by Geography

Alerts LATEST ALERTS

  • Turkey Cannabis use to be expanded to pharmaceutical sector ...
  • Thailand Impact of suspension of prime minister on cannabis ban unclear ...
  • Kazakhstan President signs change to industrial hemp law ...
  • Thailand HHC added to psychotropic substances list ...
  • Thailand Health ministry delays cannabis regulation enforcement ...
  • Thailand DTTAM says cannabis shops with GACP certification can stay open ...
  • Thailand Cannabis restricted to medical use only, with recreational use banned ...
  • Netherlands Coffee shop experiment among ‘controversial’ topics deferred until elections ...
  • United States House votes to let doctors recommend medical cannabis to veterans ...
  • Germany Growing consensus for tighter control over medical cannabis distribution ...
  • Italy Tilray obtains authorisation to distribute medical cannabis ...
  • Arkansas - United States Courts lifts injunction preventing ban on intoxicating hemp-derived products ...
News analysis

New US surgeon general nominee not likely to be an ally to cannabis industry

Written by || 20th May 2025 || News analysis | Cannabis – medical | Cannabis – recreational | Health and science | Policy and Politics | Psychedelics | Regulation and legislation | GeographiesNorth America United States

The cannabinoid sector is unlikely to find an ally in new US surgeon general nominee Casey Means. However, for those hoping for further progress towards a viable commercial psychedelics market in the country, she may prove to be a friend in the halls of power.

Contact a sales agent
I'm already a subscriber

Freddie Dawson

Senior contributing editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the CannIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.